PRSBC and PRSER+ were associated with larger odds ratio estimates than PRSER- in predicting breast cancer risk, consistent with the fact that most breast cancers in men are ER positive, including those harboring BRCA1 and BRCA2 pathogenic variants (26). The gene discussed is ESR1; the disease is breast carcinoma.